Airsonett is a Swedish medical device company that leads the way in the development of non-pharmaceutical treatment of allergic asthma and eczema. We do this by providing Airsonett AIR4, a safe and effective home treatment device that improve health-related quality of life. Main owners are Industrifonden, SEB Venture Capital, Magnus Lundberg and Fåhraeus Startup & Growth. Airsonett has an impressive patent portfolio and has invested heavily in clinical research and product development. Air4 creates a sleep zone that protects you from the exposure to allergens and particles that occur at night and we believe that everyone deserves to breathe perfectly clean air while they sleep. Air4 was initially created for people with severe atopic asthma who, in spite of taking asthma medication, still has poorly controlled asthma. Air4 is recommended by healthcare professionals as an effective at-home treatment for allergic asthma and other allergy induced diseases such as rhinitis and eczema. Using Air4 has no pharmacological side effects and is suitable for both adults and children.